Atlas Trials

Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer

Clinical trial NCT00083109 · COMPLETED

Trial details

NCT number
NCT00083109
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
Start date
2004-03-01
Primary completion
2005-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.